RCS - Ilika plc - 2024 Conference Schedule

IlikaAnnouncement

15/01/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240115:nRSO6021Za&default-theme=true

RNS Number : 6021Z  Ilika plc  15 January 2024

Ilika plc

("Ilika" or the "Company")

 

 

2024 Conference Schedule

 

Ilika to Attend Major Global Events to Promote Stereax® and Goliath Progress

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces its
conference and trade show schedule for the first half of 2024 - with the team
attending several major MedTech and Automotive conferences. At each event
Ilika representatives will either give a presentation, chair a session, form
part of a panel or be available at a booth, enabling thought-leadership
exchange and engagement with key industry peers and prospective business
partners.

 

Ilika will use the MedTech conferences to further promote its developing
relationship with Cirtec Medical and to provide updates on its ten-year
manufacturing licence to produce the Stereax range of mm-scale batteries at
Cirtec's facility. The Company will use its attendance at Automotive
conferences to raise the profile of its programme to manufacture and test
batches of Goliath pouch cells as development continues to target delivery of
fully characterised cells to its customers.

 

Medical Devices Conferences

 

North American Neuromodulation Society (NANS) Annual Meeting

For the first time, Ilika and Cirtec Medical will be sharing a booth (#505) to
jointly promote Stereax miniature solid state batteries at the 2024 NANS
Annual Meeting, on January 18-21 in Las Vegas, USA.

 

Medical Device and Manufacturing (MD&M) West

MD&M will be held on February 6-8 in Anaheim, USA where Ilika will give a
presentation to the Medical Battery Conference section of the show, discussing
the potential benefits Stereax solid state batteries can deliver in
miniaturisation and active implanted medical devices.

 

Automotive and Electric Vehicle Conferences

 

International Battery Seminar (IBS)

At IBS, March 12-15 in Orlando, USA, Ilika's Product Manager, Dr Denis Pasero,
will chair the "Solid State Battery Program Update" session.

 

Battery Tech Expo

At Battery Tech Expo, April 25 in Silverstone, UK, Ilika will provide an
update on its progress developing the first Goliath solid state battery
product and its activity securing the scale-up of its technology.

 

MOVE 2024

CEO Graeme Purdy will join a panel to discuss solid state batteries for
transportation at MOVE 2024, on June 19-20 in London. Ilika will use the event
to network and identify trends emerging from other prestigious shows in the
calendar.

 

Graeme Purdy, Ilika CEO stated: "This is an exciting year for Ilika with both
our Goliath and Stereax solid state batteries moving forward in line with our
roadmap. Last year, we finalised our partnership with Cirtec Medical to
manufacture and commercialise our Stereax mm-scale batteries, and we achieved
our D4 development point and lithium-ion energy density parity with our
Goliath technology for electric vehicles. As we continue with our roadmap this
year, we'll be presenting updates at key worldwide events, showing how our
technology can transform both the EV and the MedTech markets."

 

 For more information contact:
 Ilika plc                                               www.ilika.com (http://www.ilika.com/)
 Graeme Purdy, Chief Executive Officer                   Via Walbrook PR
 Jason Stewart, Chief Financial Officer

 Liberum Capital Limited (Nomad and Joint Broker)        Tel: 020 3100 2000
 Andrew Godber,
 Nikhil Varghese

 Joh. Berenberg, Gossler & Co. KG (Joint Broker)         Tel: 020 3207 8700
 Matthew Armitt, Mark Whitmore, Detlir Elezi,
 Mara Grasso

 Walbrook PR Ltd             Tel: 020 7933 8780 / Ilika@walbrookpr.com
 Nick Rome, Charlotte Edgar, Joe Walker

 

About Ilika plc - https://www.ilika.com (https://www.ilika.com/)

Ilika specialises in the developing and commercialisation of solid state
batteries. The Company's mission is to rapidly develop leading-edge
IP, manufacture and license solid state batteries for markets that cannot be
addressed with conventional batteries due to their safety, charge rates,
energy density and life limits. The Company achieves this by using
ceramic-based lithium-ion technology that is inherently safe in manufacture
and usage, higher thermal tolerance and easier to recycle which
differentiates our products from existing batteries.

 

The Company has two product lines. Its Stereax batteries which are designed
for powering miniature medical implants, industrial wireless sensors and
specialist internet of Things (IoT) applications and the Goliath large format
batteries designed for EV cars and cordless appliances.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASFDFWEELSEEF